An exciting application of the Briard dog model in human blindness is its use as an experimental platform for investigating gene therapy (Le Meur et al., 2007), involving the injection of wild type Rpe65 gene encapsulated in a viral vector, such as the adeno‐associated virus type 2 (AAV2), into the eye. This evidence concerns the gene RPE65 and blindness (disorder).